Advagraf · DIN 02331667 · 3 mg · extended release capsule
Limited Use, Reason for Use code 410 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 410 required
Write on scriptReason for Use code 410 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 410
Reason for Use code 410
For prophylaxis of organ rejection in adult patients receiving allogeneic kidney transplants
Coverage limit:
LU Authorization Period: Indefinite
Savings card: innoviCares lists Advagraf (Ontario list dated 2026-09-10) — pays part of the brand-versus-generic difference after other coverage; free sign-up. (innovicares.ca ↗)
1 brand, same coverage
Advagraf · DIN 02331667
Manufacturer: Astellas Pharma Canada Inc.; listing date 2011-03-15
Health Canada: Marketed since 2010-04-05 · brand ADVAGRAF · ATC L04AD02 TACROLIMUS · form Capsule (extended-release) · route Oral · ingredients TACROLIMUS 3 MG · company Astellas pharma canada inc · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02331667)
Source record
DIN 02331667: Advagraf
Raw flags: sec12=Y, sec3=Y
Item: 920000621; group id 967; item number 2297; lccId 00200; manufacturer id ASE
Source form: ER Cap; strength: 3mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $8.5188; ministry $4.6853
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02331667
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81736
Interchangeable products
Sandoz Tacrolimus XR · DIN 02528622 · $4.6853
Shortage status: not checked (no credentials)